"The view out there in the analyst community is that the future of Biogen depends on the next deal that we do and that's not ...

Canadian real estate has seen some positive growth but won’t recover to peak valuations for another half decade. That was the ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

That’s because the looming threat of upcoming tariffs to be imposed on Canadian goods by Donald Trump’s incoming administration is expected to gut the country’s economic growth. Investors are pricing ...

"Overall, it was an update on the producer price landscape that was more benign than expected, although it goes without saying tomorrow's core-CPI figures will be far more market-moving," Ian Lyngen, ...

“While resale prices have found a floor across most markets, it’s still a long way back to the 2022 highs — as we’ve often said, think years not months,” Robert Kavcic, a senior economist with BMO ...

BMO Capital analyst Brian Quast has reiterated their bullish stance on BTG stock, giving a Buy rating on January 7.Stay Ahead of the ...

The question of potential recoveries from subrogation of claims has emerged in relation to the ongoing wildfires in Los ...

Detailed price information for Choice Properties REIT (CHP-UN-T) from The Globe and Mail including charting and trades.

Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced the appointment of Colin Hamilton as ...

Energy stocks have surged 5% so far this year, outpacing the S&P 500 index's 1% loss after lagging the market for the last ...

On Friday, IGM Biosciences Inc (IGMS) stock saw a decline, ending the day at $2.09 which represents a decrease of $-4.11 or -66.29% from the prior close of $6.2. The stock opened at $2.01 and touched ...